Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Clinical trial NCT07354828 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07354828
Sponsor: Shenyang Northern Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)

Start date: 2025-12-30
Primary completion: 2028-12-30
Enrollment: 3500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.